Furthermore, MTX administration has been associated with the risk of increased alanine aminotransferase/aspartate aminotransferase (ALT/AST) enzyme levels in patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) (6, 7). The gene discussed is GPT; the disease is rheumatoid arthritis.